Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Medicure Inc
V.MPH
Alternate Symbol(s):
MCUJF
Healthcare
Biotechnology
Medicure Inc. is a Canada-based pharmaceutical company. The Company is focused on the development and commercialization of therapies for the United States cardiovascular market. The focus of the Company is the marketing and distribution of AGGRASTAT (tirofiban hydrochloride) injection and ZYPITAMAG (pitavastatin) tablets in the United States, where they are sold through the Company’s United...
States subsidiary, Medicure Pharma Inc. The Company also operates Marley Drug, Inc. (Marley Drug), a pharmacy located in North Carolina that offers an Extended Supply drug program serving all 50 states, Washington D.C. and Puerto Rico. Marley Drug is committed to improving the health status of its patients and the communities they serve while reducing overall health care costs for employers and other health care consumers. AGGRASTAT is indicated to reduce the rate of thrombotic cardiovascular events in patients with non-ST elevation acute coronary syndrome (NSTE-ACS).
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:MPH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
(9)
•••
Winnipeg40
X
View Profile
View Bullboard History
Comment by
Winnipeg40
on Jan 18, 2023 10:09pm
RE:RE:RE:RE:RE:New Article
Great deal...take a bunch of cash out of the Company in related party transactions, an inflated CEO salary for working part-time and 60% of time on multiple other Companies, private and public while
...more
(7)
•••
clamet
X
View Profile
View Bullboard History
Post by
clamet
on Jan 13, 2023 4:07pm
MedicureTurns25: A Conversation with our CEO as we celebrate
#MedicureTurns25: A Conversation with our CEO as we celebrate 25 years September 9, 2022 This month, Medicure turns 25 years old. Medicure's CEO Albert D. Friesen
...more
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Dec 30, 2022 8:40am
RE:RE:RE:RE:New Article
CEO buys another $67,000 since last post.
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Dec 08, 2022 7:29pm
RE:RE:RE:New Article
CEO buys another $14,140 worth of stock as he continues to add to his holdings.
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Dec 01, 2022 11:26am
RE:RE:New Article
CEO buys another $16,720 worth of stock further adding to his recent buys. $16,720 +15,200 vol $1.10 each
(9)
•••
Winnipeg40
X
View Profile
View Bullboard History
Comment by
Winnipeg40
on Nov 28, 2022 12:32pm
RE:RE:RE:Message to Shareholders, November 2022
Appears real investors agree, leaving the MPH share price where it was prior to the announcement. Comparing first 9 months of 2021 Vs 2022 not relevant. Have to look at
...more
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Nov 25, 2022 12:36pm
RE:RE:Message to Shareholders, November 2022
"New entrant for Aggrastat allowed into the Market this month and completely off patent in Q1." MPH has no knowledge that it was launched this month according to the conference call. It
...more
(9)
•••
Winnipeg40
X
View Profile
View Bullboard History
Comment by
Winnipeg40
on Nov 25, 2022 8:44am
RE:Message to Shareholders, November 2022
New entrant for Aggrastat allowed into the Market this month and completely off patent in Q1. Zypitimag sales not growing all that fast to replace and Marley Drugs under MPH Management has
...more
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Nov 24, 2022 6:24pm
$1.4 million EBITDA for Q3
MEDICURE REPORTS FINANCIAL RESULTS FOR QUARTER ENDED SEPTEMBER 30, 2022 V.MPH | 1 hour ago WINNIPEG, MB, Nov. 24, 2022 /PRNewswire
...more
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Post by
prophetoffactz
on Nov 24, 2022 6:22pm
Message to Shareholders, November 2022
Message to Shareholders, November 2022 Medicure’s business growth now has four focuses: AGGRASTAT® (tirofiban hydrochloride) injection continues to hold the majority of the patient market share
...more
(9)
•••
Winnipeg40
X
View Profile
View Bullboard History
Comment by
Winnipeg40
on Oct 27, 2022 11:22pm
RE:RE:New Article
That would be about 1/2 the related party fees he takes in LOL Not to mention a 300K salary for someone who made an investment a few years ago with MPH's money of 10 Million and was written
...more
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Oct 21, 2022 10:47pm
RE:New Article
The CEO has now bought >$71,000 worth of shares in recent months having added another $11,000 last Friday.
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Oct 18, 2022 9:37pm
RE:RE:RE:RE:New Article
"Aggrastat's net realized price to MPH will likely decrease over the next 12-24 months by 50%-75%." Given MPH's gross margin last quarter was only 58.6% there is no chance of that
...more
(9)
•••
Winnipeg40
X
View Profile
View Bullboard History
Comment by
Winnipeg40
on Oct 17, 2022 4:56pm
RE:RE:RE:New Article
Aggrastat's net realized price to MPH will likely decrease over the next 12-24 months by 50%-75%. Contracts with US hospitals are typically for one year and that is for pricing. If an
...more
(215)
•••
prophetoffactz
X
View Profile
View Bullboard History
Comment by
prophetoffactz
on Oct 16, 2022 2:12pm
RE:RE:New Article
The CEO has purchased >$60,000 worth of stock in the last five months. He's comfortable with MPH's direction. There has been no insider selling. AGGRASTAT's price has already been
...more
Prev
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
An Opportunity to Join Pulsar Helium on the Ground in Minnesota for a Historic Reservoir Flow Test
Significant New Silver Discoveries in the Famous Keno Hill District in the Yukon